Unterehmen auf Watchlist setzen
Acelyrin
ISIN: US00445A1007
WKN: A3EDH4
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Acelyrin · ISIN: US00445A1007 · PR Newswire (ID: 20250207NY14613)
07 Februar 2025 09:22PM

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of ACELYRIN, INC.


NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by ACELYRIN, INC. (NASDAQ: SLRN) and its board of directors concerning the proposed acquisition of the company by Alumis Inc. (NASDAQ: ALMS). Stockholders will receive 0.4274 shares of Alumis common stock for each share of ACELYRIN stock that they hold. After closing, ACELYRIN stockholders will own approximately 45% of the combined company. The transaction is expected to close in the second quarter of 2025.

If you are a stockholder of ACELYRIN, INC. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/slrn/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com

Attorney Advertising. Prior results do not guarantee a similar outcome.

Cision View original content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-acelyrin-inc-302371449.html

SOURCE Rowley Law PLLC

Visuelle Wertentwicklung / Kursverlauf · Acelyrin
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942